We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-18.13%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$234M
AUM Growth
-$57.5M
Cap. Flow
+$8.43M
Cap. Flow %
3.6%
Top 10 Hldgs %
19.04%
Holding
125
New
1
Increased
41
Reduced
24
Closed
–

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$1.68M
2
PBYI icon
Puma Biotechnology
PBYI
+$1.04M
3
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$999K
4
ACRS icon
Aclaris Therapeutics
ACRS
+$995K
5
TRUP icon
Trupanion
TRUP
+$639K

Top Sells

Rank Stock Value
1
AYX
Alteryx Inc
AYX
+$914K
2
TWLO icon
Twilio
TWLO
+$875K
3
EEFT icon
Euronet Worldwide
EEFT
+$760K
4
TTD icon
Trade Desk
TTD
+$754K
5
GHDX
Genomic Health, Inc.
GHDX
+$687K

Sector Composition

Rank Sector Weight
1 Technology 25.36%
2 Healthcare 24%
3 Communication Services 11.23%
4 Consumer Discretionary 10.45%
5 Financials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNPS icon
76
Synopsys
SNPS
$71.6B
$1.57M 0.67%
18,804
– –
GHDX
77
DELISTED
Genomic Health, Inc.
GHDX
$1.57M 0.67%
24,665
-9,794
-28% -$687K
NTNX icon
78
Nutanix
NTNX
$16.1B
$1.57M 0.67%
38,929
+7,009
+22% +$289K
PBYI icon
79
Puma Biotechnology
PBYI
$398M
$1.56M 0.67%
73,876
+34,667
+88% +$1.04M
EPAM icon
80
EPAM Systems
EPAM
$5.58B
$1.55M 0.66%
13,631
– –
TTEC icon
81
TTEC Holdings
TTEC
$124M
$1.55M 0.66%
56,105
– –
ASMB icon
82
Assembly Biosciences
ASMB
$498M
$1.52M 0.65%
5,740
+1,824
+47% +$528K
AKAM icon
83
Akamai
AKAM
$15.6B
$1.52M 0.65%
24,892
– –
CLR
84
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$1.5M 0.64%
37,834
– –
MPWR icon
85
Monolithic Power Systems
MPWR
$61.4B
$1.49M 0.64%
12,927
– –
PEGA icon
86
Pegasystems
PEGA
$5.09B
$1.49M 0.64%
62,778
– –
PFBC icon
87
Preferred Bank
PFBC
$1.24B
$1.47M 0.63%
33,915
+3,917
+13% +$200K
TTSH
88
DELISTED
Tile Shop Holdings
TTSH
$1.47M 0.63%
269,004
+68,715
+34% +$420K
EVC icon
89
Entravision Communication
EVC
$1.02B
$1.47M 0.63%
503,357
+115,556
+30% +$452K
LMAT icon
90
LeMaitre Vascular
LMAT
$2.37B
$1.46M 0.63%
62,205
+10,663
+21% +$291K
EEFT icon
91
Euronet Worldwide
EEFT
$3.19B
$1.46M 0.62%
14,425
-6,868
-32% -$760K
SUPN icon
92
Supernus Pharmaceuticals
SUPN
$2.71B
$1.45M 0.62%
44,665
+3,661
+9% +$157K
MDGL icon
93
Madrigal Pharmaceuticals
MDGL
$12.6B
$1.43M 0.61%
13,659
+6,458
+90% +$999K
GEO icon
94
The GEO Group
GEO
$4B
$1.43M 0.61%
73,774
– –
FIZZ icon
95
National Beverage
FIZZ
$3.06B
$1.42M 0.61%
39,700
+2,206
+6% +$102K
KPTI icon
96
Karyopharm Therapeutics
KPTI
$155M
$1.4M 0.6%
10,230
+3,430
+50% +$579K
ACRS icon
97
Aclaris Therapeutics
ACRS
$715M
$1.39M 0.59%
189,437
+96,548
+104% +$995K
CASA
98
DELISTED
Casa Systems, Inc. Common Stock
CASA
$1.38M 0.59%
106,908
-11,524
-10% -$165K
PNFP icon
99
Pinnacle Financial Partners Inc
PNFP
$15.8B
$1.35M 0.58%
29,448
– –
NTRA icon
100
Natera
NTRA
$36.4B
$1.34M 0.57%
102,617
+20,834
+25% +$380K
1 2 3
4
5

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Capital Impact Advisors held 125 positions worth $234M, down 20% from $292M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Capital Impact Advisors deployed $8.43M of net new capital in Q4 2018, opening 1 new position and adding to 41 existing holdings. Its largest new stake was Okta: 28,303 shares worth $1.74M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Alteryx Inc, an estimated $914K trimmed.

  • Capital Impact Advisors's largest Q4 2018 buy was Okta: 28,303 shares worth $1.74M.
  • Capital Impact Advisors added most to Puma Biotechnology in Q4 2018, an estimated $1.04M increase.
  • Capital Impact Advisors's biggest Q4 2018 reduction was Alteryx Inc, cutting an estimated $914K.
  • Capital Impact Advisors's ten largest holdings make up 19% of its $234M portfolio in Q4 2018.
  • Capital Impact Advisors opened 1 new position and closed 0 in Q4 2018.
  • Capital Impact Advisors's portfolio value fell 20% quarter-over-quarter to $234M.

Based on Capital Impact Advisors's 13F filing for Q4 2018, filed 8 Mar 2019.